Results 191 to 200 of about 3,896,424 (394)
Ubiquitination‐Driven Reprogramming of Proteostasis in Metastasis
The DCAF12–TRiC/CCT axis is a key regulator of metastasis in cancer. By reprogramming proteostasis to ensure efficient protein folding, it drives progression through a dual mechanism: enhancing cancer cell motility and invasiveness while concurrently activating pro‐growth and survival pathways.
Dongping Wei, Jiayan Chen, Yaping Xu
wiley +1 more source
Many drugs can act on multiple targets or disease pathways, regardless of their original purpose. Drug repurposing involves reevaluating existing compounds for new medical uses. This can include repositioning approved drugs, redeveloping unapproved drugs,
Paola Patrignani +6 more
doaj +1 more source
Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's disease [PDF]
Jasmine Morales +8 more
openalex +1 more source
Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
Saravanan Sekaran, Suresh Kumar R Sekar
openalex +1 more source
Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing [PDF]
Jayanta Kumar Das +4 more
openalex +1 more source
Combining machine learning and probabilistic statistical learning is a powerful way to discover and design new materials. A variety of machine learning approaches can be used to identify promising candidates for target applications, and causal inference can help identify potential ways to make them a reality.
Jonathan Y. C. Ting, Amanda S. Barnard
wiley +1 more source
Supplementary Tables 1 - 6, Figures 1 - 4 from Drug Repurposing for Gastrointestinal Stromal Tumor
Ziyan Y. Pessetto +4 more
openalex +2 more sources
Repurposed drugs and their progression against COVID-19 [PDF]
Heena Rani +3 more
openalex +1 more source
Artificial Intelligence for Bone: Theory, Methods, and Applications
Advances in artificial intelligence (AI) offer the potential to improve bone research. The current review explores the contributions of AI to pathological study, biomarker discovery, drug design, and clinical diagnosis and prognosis of bone diseases. We envision that AI‐driven methodologies will enable identifying novel targets for drugs discovery. The
Dongfeng Yuan +3 more
wiley +1 more source

